SION Sionna Therapeutics, Inc.
Healthcare$42.88+4.25%ClosedMarket Cap: $1.94B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
6.41
P/S
0.00
EV/EBITDA
-20.34
DCF Value
$1.23
FCF Yield
-3.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-27.3%
ROA
-28.1%
ROIC
-33.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-29.6M | $-26.8M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-23.6M | $-20.4M | $— | — |
| FY null | $0.00 | -Infinity% | $-89.0M | $-75.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-23.8M | $-20.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-21.9M | $-18.1M | $— | — |
| Q1 null | $0.00 | NaN% | $-19.7M | $-16.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-18.1M | $-15.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-70.6M | $-61.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-28.0M | $-25.4M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-11.3M | $-8.6M | $— | — |
| Q1 null | $0.00 | NaN% | $-13.1M | $-11.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-12.6M | $-11.9M | $-0.27 | — |